Net Asset Value(s)
Summary by AI BETAClose X
Templeton Emerging Markets Investment Trust reported unaudited cum-income NAV as at 05 November 2026 of £2,853.485m (317.09p per share) and unaudited ex-income NAV of £2,813.460m (312.64p per share); the income component equals £40.025m or 4.45p per share, representing an approximately 1.42% uplift versus the ex-income NAV. Both NAVs are calculated using bid prices in accordance with AIC recommendations and are unaudited.
Templeton Emerging Markets IT PLC
06 November 2026
Templeton Emerging Markets Investment Trust PLC ('TEMIT')
On behalf of TEMIT, Franklin Templeton Investment Trust Management Limited reports the unaudited cum-income net asset value ('NAV') of TEMIT as at
05 November 2026 was £2853.485m, representing a NAV of 317.09 pence per share.
The unaudited ex-income NAV of TEMIT as at 05 November 2026 was £2813.460m, representing a NAV of 312.64 pence per share.
In accordance with the Association of Investment Companies recommendations, the cum-income NAV has been calculated based on the total value of underlying assets,
including accumulated or accrued income, and using bid price information relating to the underlying assets.
The ex-income NAV has been calculated based on the total value of underlying assets, excluding these income elements, and using bid price information relating to the underlying assets.
Portfolio data for TEMIT can be found on the website www.TEMIT.co.uk.
For information please contact Client Dealer Services on freephone 0800 305 306.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Latest directors dealings
- 4 hours ago Johnson Matthey
- 5 hours ago Galliford Try
- 5 hours ago Galliford Try
- 5 hours ago Centrica
- 6 hours ago Smith & Nephew